China

Showing 15 posts of 258 posts found.

Novo Nordisk image

Novo Nordisk to expand Beijing R&D centre

September 25, 2012
Research and Development, Sales and Marketing Beijing, China, Novo Nordisk, R&D

Novo Nordisk is investing $100 million into enlarging its R&D facilities in Beijing into a state-of-the-art centre. Located in the …

China sees fresh wave of drug price cuts

September 21, 2012
Manufacturing and Production, Sales and Marketing China, Lunt, NDRC, ageing

China has unveiled yet another round of price cuts to prescription medicines. The price cuts cover more than 200 formulations …

Pfizer and Hisun sign China generics deal

September 13, 2012
Manufacturing and Production, Sales and Marketing China, Pfizer, branded generics, emerging markets, generics

Pfizer has unveiled a new joint venture with with China’s Zhejiang Hisun Pharmaceuticals. It is one of the first joint …

MedImmune

MedImmune signs China deal

September 11, 2012
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, China, MedImmune, WuXi, emerging markets, rheumatoid arthritis

MedImmune has sealed a joint venture with Shanghai-based WuXi AppTec to develop a novel biologic for autoimmune and inflammatory diseases …

China sets February 2013 deadline for excipient regulations

August 14, 2012
Manufacturing and Production China, IPEC, SFDA, Taylor

China has moved swiftly ahead with new regulations governing quality rules for pharmaceutical excipients, including new requirements for pharma firms …

WuXi continues strong growth

August 14, 2012
Manufacturing and Production China, WuXi

Chinese contract research firm Wuxi saw its revenue grow strongly in the second quarter, with its laboratory services playing a …

Huge increase in emerging market spending to lift pharma

July 16, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, IMS, emerging markets, pharmerging

The global pharmaceutical market is set to return to stronger growth of 5-7% by 2016, according to a new forecast. …

R&D, East & West: Lilly invests in its global research network

July 10, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Asia, China, R&D, diabetes, lilly

Eli Lilly officially opened its new research facilities at its R&D base in Erl Wood in Surrey in April. The …

China sets out quality rules for pharma excipients

July 3, 2012
Manufacturing and Production China, GMP, IPEC, manufacturing

China’s State Food & Drug Administration has published a draft regulation laying out a number of new measures for boosting …

BMS invests $15 million in Asian diabetes programme

June 11, 2012
Sales and Marketing Asia, BMS, China, India, Onglyza, diabetes

Bristol-Myers Squibb has invested $15 million into its ‘Together on Diabetes’ campaign in India and China. Together on Diabetes is …

China bans medicines formulated in toxic capsules

April 17, 2012
Manufacturing and Production China, SFDA, impurities, manufacturing

China’s State Food and Drug Administration (SFDA) has banned the sale of 13 medicines thought to be manufactured using contaminated …

Steve Yang

Innovating in China’s pharma market

April 12, 2012
Research and Development AstraZeneca, China, R&D, Steve Yang, emerging markets

The challenges that China and the wider Asia region face in healthcare represent big opportunities for multinational pharma companies. Cases of …

Novasep expands in China, raises €40m for investments

April 3, 2012
Manufacturing and Production China, Novasep, Shanghai, manufacturing

French processing equipment supplier Novasep has opened a new facility in China to meet what it says is increasing demand …

Asymchem plans additional investment in Dunhua facility

February 21, 2012
Manufacturing and Production Asymchem, China, Dunhua, manufacturing

China’s Asymchem Laboratories says it plans to invest another $12 million in its recently-opened manufacturing facility in Dunhua, Jilin province, …

Pfizer closes in on $545m China generics deal

February 20, 2012
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing China, Hisun, Pfizer, Zhejiang, generics

Pfizer has moved a step closer to a deal with Shanghai-based Zhejiang Hisun Pharmaceutical to develop generic drugs in China.  …

The Gateway to Local Adoption Series

Latest content